Back
Sarepta Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$22.10
Seasonality Move:
6.08%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.
Sarepta Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.49 | Buy |
| 20-day SMA: | 21.54 | Buy |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 30.87 | Sell |
| 8-day EMA: | 16.81 | Buy |
| 20-day EMA: | 9.68 | Buy |
| 50-day EMA: | 4.56 | Buy |
| 200-day EMA: | 1.24 | Buy |
Sarepta Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.69 | Buy |
| Relative Strength Index (14 RSI): | 57.4 | Buy |
| Chaikin Money Flow: | 705480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics, Inc. Stock
Is Sarepta Therapeutics, Inc. Stock a Buy?
-
Sarepta Therapeutics, Inc. share price is 22.32 while SRPT 8-day simple moving average is 21.49, which is a Buy signal.
-
The stock price of SRPT is 22.32 while Sarepta Therapeutics, Inc. 20-day SMA is 21.54, which makes it a Buy.
-
Sarepta Therapeutics, Inc. 50-day simple moving average is 20.78 while SRPT share price is 22.32, making it a Buy technically.
-
SRPT stock price is 22.32 and Sarepta Therapeutics, Inc. 200-day simple moving average is 30.87, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy or a Sell?
-
Sarepta Therapeutics, Inc. stock is rated a SellThe current Sarepta Therapeutics, Inc. [SRPT] share price is $22.32. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics, Inc. Stock Info
Market Cap:
2.3B
Price in USD:
22.32
Share Volume:
1.3M
Sarepta Therapeutics, Inc. 52-Week Range
52-Week High:
129.84
52-Week Low:
10.42
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Sarepta Therapeutics, Inc. Share Price Forecast
-
What is the Sarepta Therapeutics, Inc. stock price today?The Sarepta Therapeutics, Inc. stock price is 22.32 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics, Inc. is overvalued.
Is Sarepta Therapeutics, Inc. Stock a Buy?
-
Sarepta Therapeutics, Inc. share price is 22.32 while SRPT 8-day exponential moving average is 16.81, which is a Buy signal.
-
The stock price of SRPT is 22.32 while Sarepta Therapeutics, Inc. 20-day EMA is 9.68, which makes it a Buy.
-
Sarepta Therapeutics, Inc. 50-day exponential moving average is 4.56 while SRPT share price is 22.32, making it a Buy technically.
-
SRPT stock price is 22.32 and Sarepta Therapeutics, Inc. 200-day simple moving average is 1.24, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics, Inc.
Is Sarepta Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
Technical Analysis of Sarepta Therapeutics, Inc.
Should I short Sarepta Therapeutics, Inc. stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is 5.69, suggesting Sarepta Therapeutics, Inc. is a Buy
-
Sarepta Therapeutics, Inc. Relative Strength Index (RSI) is 57.4, which suggest Sarepta Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Sarepta Therapeutics, Inc. is ( - ), which suggest Sarepta Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Sarepta Therapeutics, Inc. is ( - ), which suggest Sarepta Therapeutics, Inc. is a Buy
* Sarepta Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.